The Use of Human Liver Banks in Pharmacogenetic Research
- 1 January 1989
- book chapter
- Published by Springer Nature
- Vol. 7, 163-171
- https://doi.org/10.1007/978-3-642-74430-3_17
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiencyBiochemistry, 1987
- Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liverBiochemical Pharmacology, 1986
- Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparationsXenobiotica, 1986
- Correlation between nortriptyline and debrisoquine hydroxylation in the human liverLife Sciences, 1983
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Identification of a New Glutathione S-Transferase in Human Liver.Acta Chemica Scandinavica, 1980
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in ManBMJ, 1972
- Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compoundsLife Sciences, 1967